Nova natura, UAB - financials and debts

Company age: 7 y. 6 mo.

Update

Nova natura - Company finances

EUR
2019
From: 2019-03-07
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 1,182,538 5,925,373 3,892,518 10,448,397 5,786,567 4,774,218 4,614,628
Profit before tax 102,850 391,197 416,558 756,387 521,641 660,839 389,036
Net profit 87,149 332,197 353,864 641,694 442,998 542,838 318,361
Equity 89,649 356,404 458,268 779,962 571,020 446,972 465,355
Liabilities 621,038 1,206,984 2,360,705 946,759 1,053,020 396,951 695,132
Non-current assets 62,746 38,286 27,540 22,600 36,723 39,788 38,821
Current assets 656,291 1,227,204 2,450,721 1,703,771 1,587,256 802,257 1,114,746
Total assets 719,037 1,265,490 2,478,261 1,726,371 1,623,979 842,045 1,153,567
Taxes paid
STI taxes - - - - 951,309 759,485 1,085,888
Social insurance contributions - - - - - 16,142 39,661
Financial indicators
Revenue change y/y - +401.1% -34.3% +168.4% -44.6% -17.5% -3.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 12.1% 26.3% 14.3% 37.2% 27.3% 64.5% 27.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 97.2% 93.2% 77.2% 82.3% 77.6% 121.4% 68.4%
Profit margin Net profit margin. Shows the overall profitability of the company. 7.4% 5.6% 9.1% 6.1% 7.7% 11.4% 6.9%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 8.7% 6.6% 10.7% 7.2% 9.0% 13.8% 8.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 6.9 3.4 5.2 1.2 1.8 0.9 1.5
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 656,966 2,962,687 1,946,259 3,918,100 1,928,856 1,397,318 1,153,657

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Nova natura - Social security debts

The company had no debts to Sodra

Nova natura - VMI tax arrears

From To Overdue, €
2026-08-02 2026-08-07 20.03
2025-10-08 2025-10-11 950.63
2025-10-02 2025-10-02 2715.26
2025-09-30 2025-10-01 2661.67
2025-09-19 2025-09-29 2.06
2025-09-03 2025-09-08 10476.49
2025-09-01 2025-09-02 11124.5
2025-08-31 2025-08-31 10604.83
2025-07-01 2025-07-20 10119.7
2025-06-30 2025-06-30 9744.73
2025-06-20 2025-06-20 22606.38

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Nova natura, UAB (code 305063819) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €4.61M and net profit of €318.4K, with a net profit margin of 6.9%. Revenue declined by 3.3% year on year and by 20.2% over two years, moving down from €5.79M in 2023 to €4.77M in 2024 and then to the latest level in 2025. Profitability also eased from the 2024 peak, when net profit reached €542.8K and the margin was 11.4%, after €443.0K in 2023.

At the end of 2025, total assets stood at €1.15M, equity at €465.4K and liabilities at €695.1K. The equity ratio was 40.3% and debt-to-equity 1.49, indicating a leveraged but still moderately capitalised balance sheet. Return on equity was 68.4%, return on assets 27.6%, and asset turnover 4.00x, showing efficient use of assets despite the lower revenue base. Revenue per employee was €1.15M, while profit per employee was €79.6K.